CannTrust Holdings Inc is a Canadian licensed producer of medical and recreational cannabis products. The company cultivates, processes and distributes a range of offerings, including dried flower, oils, pre-rolls and vape cartridges, under the CannTrust brand. Through a vertically integrated model, CannTrust oversees cultivation, manufacturing, quality assurance and distribution to serve patient and adult-use markets across Canada.
The company’s cultivation infrastructure comprises both greenhouse and indoor facilities in Pelham and Vaughan, Ontario, where controlled environment agriculture techniques are applied to optimize cannabinoid and terpene profiles. CannTrust holds a Good Manufacturing Practices (GMP) certification from European regulators, enabling it to export medical cannabis for research and clinical trial purposes in Europe. Its Canadian distribution network reaches provincial cannabis authorities and licensed private retailers.
Founded in 2014, CannTrust expanded rapidly alongside Canada’s legalization of adult-use cannabis, securing multiple federal production and sales licenses. In 2019, the company faced regulatory compliance issues that led to a suspension of certain cultivation authorizations and a subsequent leadership restructuring. Following a period of corporate reorganization and asset divestitures in the early 2020s, CannTrust refocused on its core cultivation and product development operations, emphasizing regulatory compliance and renewal of its market position within the evolving cannabis industry.
AI Generated. May Contain Errors.
Free CNTTF Stock Alerts